Pharma welcomes Hunt to top health job
September 5, 2012Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform
The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …
Pfizer to develop phase II cancer vaccine
September 4, 2012Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine
Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
Valeant to buy dermatogy firm Medicis
September 4, 2012Sales and Marketing Valeant
Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …
Contract research news in brief
September 4, 2012Research and Development CRO, Charles River, WuXi
Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
Genzyme recalls drug on failed stability testing
September 4, 2012Manufacturing and Production Genzyme, Stability Testing, pharma recalls
Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …
Cash incentive for NHS digital info sharing
September 3, 2012NHS, digital
NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …
Cash incentive for NHS digital info sharing
September 3, 2012NHS, digital
NHS bodies which develop new digital services for sharing information could be eligible for thousands of pounds worth of funding, …
Novartis cheered by COPD trial results
September 3, 2012Research and Development COPD, ERS, Novartis
One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …
The ex-CEO’s Job Blog – part 1
September 3, 2012Medical Communications David Barratt, Jobs, careers, pharma jobs, restructuring, the ex-CEO's job blog
I have seen a lot in my healthcare career. Been round the block more than twice, as they say. I …
New quad HIV pill passed by FDA
September 2, 2012Sales and Marketing FDA, Gilead, HIV, stribild
Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …
J&J buys into Genmab cancer drug
August 31, 2012Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma
Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …
ABPI worried by public ignorance about medicines
August 31, 2012Sales and Marketing ABPI, UK
People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …
Publicis creates new digital agency Razorfish Healthware
August 31, 2012Medical Communications Razorfish Healthware, advertising, digital, publicis
Two Publicis agencies, Razorfish Health and Publicis Healthware International are to be merged to create Razorfish Healthware, which will focus …
CPC Healthcare joins Indigenus network
August 31, 2012Medical Communications CPC Healthcare Communications, CementBloc, Indegenus, Indigenus
CPC Healthcare Communications, based in Toronto, Canada, has joined Indigenus, the global network of independent healthcare agencies.The Indigenus network spans …
Patient death halts BMS hep C trial
August 30, 2012Sales and Marketing BMS, HCV, hepatitis C
Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …
Genzyme ‘confident’ of FDA nod for MS drug
August 29, 2012Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis
Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …
Efient fails to prove superiority to Plavix
August 29, 2012Brillinta, Efient, Plavix, prasugrel, ticagrelor
Daiichi Sankyo and Lilly’s heart drug Efient has failed to come up to the mark in a late-stage trial which …
Innovation scorecard gets ABPI thumbs-up
August 29, 2012Sales and Marketing NHS, NICE, market access
An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …
AstraZeneca poaches Soirot from Roche to be new chief executive
August 28, 2012Sales and Marketing AstraZeneca, Soirot
AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …
Novartis’ myelofibrosis treatment approved in Europe
August 28, 2012Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis
Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
